However, stage II CRC patients with expression of the stem-like markers CD44, LGR5, SOX2 and OCT4 in the tumors had a significantly worse prognosis compared to those with lower expression and showed a tendency to benefit from adjuvant treatment [64]. Here, POU5F1 is linked to colorectal carcinoma.